Table 1.
Results of Vitek 2 antimicrobial susceptibility testing of Staphylococcus aureus isolates
| Identity of S. aureus isolatea | Total no. of isolates | No. of susceptible and/or resistant isolates/total no. of isolates (%) by Vitek 2b |
|||
|---|---|---|---|---|---|
| Oxacillin S and cefoxitin R (S/R) | Oxacillin R and cefoxitin R (R/R) | Oxacillin R and cefoxitin S (R/S) | Oxacillin S and cefoxitin S (S/S) | ||
| MRSA mecC positive | 62 | 55/62 (88.7) | 7/62 (11.3) | 0/62 (0) | 0/62 (0) |
| MRSA mecA positive | 455 | 4/455 (0.9) | 446/455 (98.0) | 5/455 (1.1) | 0/454 (0) |
| MSSA mecA and mecC negative | 379 | 0/379 (0) | 0/379 (0) | 4/379 (1.1) | 375/379 (98.9) |
a
As determined by bacterial whole-genome sequencing.
b
S, susceptible; R, resistant; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus.